U.S. Department of Health and Human Services (HHS) officials last week briefed the Republican and Democratic staff of a key [...] …
Category: Regulatory
SK Life Science recently issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. The New [...] …
Sagebrush Health, a Nevada-based STD clinic, notched a partial legal victory on Monday when the Health Resources and Services Administration [...] …
Four major drug manufacturers and a drug industry vendor recently urged a Washington D.C. federal court to reject the government [...] …
The Trump administration’s recent efforts to restructure the Department of Health and Human Services (HHS)—including division consolidations and the elimination [...] …
AstraZeneca announced today that it will exempt Arkansas 340B providers from its contract pharmacy restrictions, two days after a state [...] …
The leaders of a Senate panel that oversees several key federal health agencies this week invited Health and Human Services [...] …
An Arkansas state official yesterday ordered AstraZeneca to restore access to 340B drugs at all contract pharmacy locations, marking the [...] …
A federal judge yesterday delayed ruling on Sagebrush Health’s request for emergency relief after the government apparently reversed course and [...] …
In a sweeping overhaul of the nation’s top government health agencies, the U.S. Department of Health and Human Services (HHS) [...] …